TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response
Authors
Keywords
-
Journal
JCI Insight
Volume 6, Issue 13, Pages -
Publisher
American Society for Clinical Investigation
Online
2021-07-08
DOI
10.1172/jci.insight.146076
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neutrophils as regulators of cardiovascular inflammation
- (2020) Carlos Silvestre-Roig et al. Nature Reviews Cardiology
- Fatal heart disease among cancer patients
- (2020) Kelsey C. Stoltzfus et al. Nature Communications
- The cancer patient and cardiology
- (2020) José Luis Zamorano et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cancer therapy shapes the fitness landscape of clonal hematopoiesis
- (2020) Kelly L. Bolton et al. NATURE GENETICS
- Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association
- (2019) Umberto Campia et al. CIRCULATION
- Wnt5a-Mediated Neutrophil Recruitment Has an Obligatory Role in Pressure Overload–Induced Cardiac Dysfunction
- (2019) Ying Wang et al. CIRCULATION
- Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation
- (2019) Silvia Mas-Peiro et al. EUROPEAN HEART JOURNAL
- A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
- (2019) Steffen Boettcher et al. SCIENCE
- Cardiovascular Disease, Aging, and Clonal Hematopoiesis
- (2019) Megan A. Evans et al. Annual Review of Pathology-Mechanisms of Disease
- PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells
- (2018) Josephine D. Kahn et al. BLOOD
- CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular DiseaseNovelty and Significance
- (2018) Soichi Sano et al. CIRCULATION RESEARCH
- Burden of cardiovascular risk factors and cardiovascular disease in childhood cancer survivors: data from the German CVSS-study
- (2018) J Faber et al. EUROPEAN HEART JOURNAL
- Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome
- (2018) Soichi Sano et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
- (2018) Ofir Wolach et al. Science Translational Medicine
- PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy
- (2018) Joanne I. Hsu et al. Cell Stem Cell
- Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction
- (2018) Sarah A. Dick et al. NATURE IMMUNOLOGY
- Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure
- (2018) Lena Dorsheimer et al. JAMA Cardiology
- Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
- (2017) Christopher J. Gibson et al. JOURNAL OF CLINICAL ONCOLOGY
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease
- (2017) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
- (2017) José J. Fuster et al. SCIENCE
- Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis
- (2017) Siew Lian Leong et al. Scientific Reports
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
- (2015) D. Cardinale et al. CIRCULATION
- Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
- (2015) M. Putt et al. CLINICAL CHEMISTRY
- Ly-6C high Monocytes Depend on Nr4a1 to Balance Both Inflammatory and Reparative Phases in the Infarcted Myocardium
- (2014) Ingo Hilgendorf et al. CIRCULATION RESEARCH
- Prevention of Anthracycline-Induced Cardiotoxicity
- (2014) Pimprapa Vejpongsa et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
- (2014) Terrence N. Wong et al. NATURE
- Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence
- (2014) Giulio Genovese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes
- (2014) Siddhartha Jaiswal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
- (2013) Steven E. Lipshultz et al. CIRCULATION
- Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase
- (2012) Saswata Talukdar et al. NATURE MEDICINE
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- Cardiovascular Complications of Cancer Therapy
- (2009) Edward T.H. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now